尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Maunsell Farris Maryanne. Director active across 2 companies, notably HAEMONETICS CORP. Aggregated, 6 disclosures have been logged. History available since 15 May 2024. The latest transaction was disclosed on 15 May 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Maunsell Farris Maryanne is VP, Chief Accounting Officer at HAEMONETICS CORP and Haemonetics CORP. The record shows 6 filings in total, and the 6 sampled filings run from 2023-05-17 to 2025-06-09; the modal transaction nature is Attribution, and the buy and sell amounts observed in these recent filings are EUR 0 and EUR 0.